# Cyrille Touzeau, MD, PhD – FDA Inspection, Aug 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/cyrille-touzeau-md-phd/bc11cbad-7e3f-4750-830e-f71ec19871ed
Source feed: FDA_Inspections

> FDA inspection 1333064 of Cyrille Touzeau, MD, PhD, August 14, 2026. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1333064
- Company Name: Cyrille Touzeau, MD, PhD
- Inspection Date: 2026-08-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dawn-c-olenjack/b5a18d10-cd4b-405e-9016-8f5274a33000)

Company: https://www.keypedia.com/companies/cyrille-touzeau-md-phd/3ac92d24-4179-4fcc-abbf-babc2fb75741

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c